KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $1.6 billion.

  • Evolent Health's Total Liabilities rose 2628.02% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 2628.02%. This contributed to the annual value of $1.4 billion for FY2024, which is 566.18% down from last year.
  • As of Q3 2025, Evolent Health's Total Liabilities stood at $1.6 billion, which was up 2628.02% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Total Liabilities peaked at $1.6 billion during Q3 2025, and registered a low of $646.0 million during Q3 2021.
  • For the 5-year period, Evolent Health's Total Liabilities averaged around $1.1 billion, with its median value being $1.3 billion (2024).
  • In the last 5 years, Evolent Health's Total Liabilities crashed by 1234.7% in 2021 and then surged by 9987.48% in 2023.
  • Quarter analysis of 5 years shows Evolent Health's Total Liabilities stood at $725.8 million in 2021, then skyrocketed by 31.97% to $957.9 million in 2022, then surged by 49.73% to $1.4 billion in 2023, then dropped by 5.66% to $1.4 billion in 2024, then grew by 19.09% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.5 billion during Q1 2025.